Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

01-12-2021 | Antibiotic | Research article

Antibiotic prescribing for acute, non-complicated infections in primary care in Germany: baseline assessment in the cluster randomized trial ARena

Authors: Regina Poss-Doering, Dorothea Kronsteiner, Martina Kamradt, Edith Andres, Petra Kaufmann-Kolle, Michel Wensing, Joachim Szecsenyi, ARena-study group

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Antimicrobial resistance is fueled by inappropriate use of antibiotics. Global and national strategies support rational use of antibiotics to retain treatment options and reduce resistance. In Germany, the ARena project (Sustainable reduction of antibiotic-induced antimicrobial resistance) intended to promote rational use of antibiotics for acute non-complicated infections by addressing network-affiliated physicians, primary care teams and patients through multiple interacting interventions. The present study documented patterns of antibiotic prescribing for patients with acute non-complicated infections who consulted a physician in these networks at the start of the ARena project. It explored variation across subgroups of patients and draws comparisons to prescribing patterns of non-targeted physicians.

Methods

This retrospective cross-sectional analysis used mixed logistic regression models to explore factors associated with the primary outcome, which was the percentage of patient cases with acute non-complicated respiratory tract infections consulting primary care practices who were treated with antibiotics. Secondary outcomes concerned the prescribing of different types of antibiotics. Descriptive methods were used to summarize the data referring to targeted physicians in primary care networks, non-targeted physicians (reference group), and patient subgroups.

Results

Overall, antibiotic prescribing rates were 32.0% in primary care networks and 31.7% in the reference group. General practitioners prescribed antibiotics more frequently than other medical specialist groups (otolaryngologists vs. General practitioners OR = 0.465 CI = [0.302; 0.719], p < 0.001, pediatricians vs. General practitioners: OR = 0.369 CI = [0.135; 1.011], p = 0.053). Quinolone prescribing rates were 9.9% in primary care networks and 8.1% in reference group. Patients with comorbidities had a higher likelihood of receiving an antibiotic and quinolone prescription and were less likely to receive a guideline-recommended substance. Younger patients were less likely to receive antibiotics (OR = 0.771 CI = [0.636; 0.933], p = 0.008). Female gender was more likely to receive an antibiotic prescription (OR = 1.293 CI = [1.201, 1.392], p < 0.001).

Conclusion

This study provided an overview of observed antibiotic prescribing for acute non-complicated respiratory tract infections in German primary care at the start of the ARena project. Findings indicate potential for improvement and will serve as comparator for the post-interventional outcome evaluation to facilitate describing of potential changes.
Appendix
Available only for authorised users
Literature
4.
go back to reference Federal Office of Consumer Protection and Food Safety P-E-GfCeV. Germap 2015: Antimicrobial Resistance and Consumption; Report on the consumption of antimicrobials and the spread of antimicrobial resistance in human and veterinary medicine in Germany. Rheinbach: Antiinfectives Intelligence, 2016. Federal Office of Consumer Protection and Food Safety P-E-GfCeV. Germap 2015: Antimicrobial Resistance and Consumption; Report on the consumption of antimicrobials and the spread of antimicrobial resistance in human and veterinary medicine in Germany. Rheinbach: Antiinfectives Intelligence, 2016.
5.
go back to reference German Federal Ministry of Health. Bundesministerium für Gesundheit. DART 2020—Antibiotika-Resistenzen bekämpfen zum Wohl von Mensch und Tier. Berlin: Bundesministerium für Gesundheit, 2015 German Federal Ministry of Health. Bundesministerium für Gesundheit. DART 2020—Antibiotika-Resistenzen bekämpfen zum Wohl von Mensch und Tier. Berlin: Bundesministerium für Gesundheit, 2015
19.
go back to reference Institute for Quality and Efficiency in Health Care (IQWiG). What are disease management programs (DMPs)? Cologne, Germany: InformedHealth.org; 2006. Updated 2007 Sep 27. Institute for Quality and Efficiency in Health Care (IQWiG). What are disease management programs (DMPs)? Cologne, Germany: InformedHealth.org; 2006. Updated 2007 Sep 27.
20.
go back to reference Zweites Gesetz zur Stärkung der pflegerischen Versorgung und zur Änderung weiterer Vorschriften (zweites Plegestärkungsgesetz (PSG II) 2015. Zweites Gesetz zur Stärkung der pflegerischen Versorgung und zur Änderung weiterer Vorschriften (zweites Plegestärkungsgesetz (PSG II) 2015.
21.
22.
go back to reference Holstiege J SM, Akmatov MK, Steffen A, Bätzing J Outpatient use of systemic antibiotics in Germany from 2010 to 2018—a population-based study. Berlin: 2019. Holstiege J SM, Akmatov MK, Steffen A, Bätzing J Outpatient use of systemic antibiotics in Germany from 2010 to 2018—a population-based study. Berlin: 2019.
28.
go back to reference Klingenberg A BT, Andres E, Kaufmann-Kolle P, Wambach V, Szecsenyi J. Was wissen Patienten über Antibiotika, und wie häufig erwarten sie deren Verordnung? Zeitschrift für Allgemeinmedizin ZFA. 2019;05/19(Deutscher Ärzteverlag Z Allg Med 2019; 95 (5)). https://doi.org/10.3238/zfa.2019.0198-0202. Klingenberg A BT, Andres E, Kaufmann-Kolle P, Wambach V, Szecsenyi J. Was wissen Patienten über Antibiotika, und wie häufig erwarten sie deren Verordnung? Zeitschrift für Allgemeinmedizin ZFA. 2019;05/19(Deutscher Ärzteverlag Z Allg Med 2019; 95 (5)). https://​doi.​org/​10.​3238/​zfa.​2019.​0198-0202.
Metadata
Title
Antibiotic prescribing for acute, non-complicated infections in primary care in Germany: baseline assessment in the cluster randomized trial ARena
Authors
Regina Poss-Doering
Dorothea Kronsteiner
Martina Kamradt
Edith Andres
Petra Kaufmann-Kolle
Michel Wensing
Joachim Szecsenyi
ARena-study group
Publication date
01-12-2021
Publisher
BioMed Central
Keywords
Antibiotic
Care
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06571-0

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.